Neoplasia/BPH

	Prognostic value of the prognostic nutritional index for patients with renal cell carcinoma: an update systematic review and meta-analysis. BMC Cancer Xu Z, Xie L, Zhang H, Han G, Guo W. PMID: 41691234 [PubMed - as supplied by publisher]
	Spatiotemporal patterns and clustering of prostate cancer incidence in China: a Bayesian modeling study of cancer registry data. BMC Public Health Zhu X, Chen Z, Ge MW, Rehman AU, Chen HL, Zhu H, Zheng B. PMID: 41691228 [PubMed - as supplied by publisher]
	Surgery or Radiotherapy: Determining Factors in Therapeutic Decision-Making for Localized Prostate Cancer in Spain. Actas Urol Esp (Engl Ed) Perez-Ardavin J, Vera-Donoso CD, Alapont JM, Martinez-Sarmiento M, Monserrat JJ, Ruíz Cerdá JL, Conde AJ, Budía Alba A. PMID: 41690467 [PubMed - as supplied by publisher]
	Bladder and rectal cancer development in prostate cancer patients treated with surgery or radiotherapy: A population-based study. Actas Urol Esp (Engl Ed) Martínez Rodríguez P, Poza Fernandez A, García Fadrique G, Acedo González J, Montero Adriá O, Mateo Cárcel N, Marzullo Zucchet L, Gómez Palomo F, Reig Ruiz C. PMID: 41690466 [PubMed - as supplied by publisher]
	Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial. Radiother Oncol Michalet M, Ronchin P, Reynaud T, Demogeot N, Gourgou S, Thézenas S, Hannoun-Lévi JM, Salem N, Quivrin M, Riou O, Charissoux M, Llacer-Moscardo C, Tosi D, Durdux C, Khalladi N, Culine S, Azria D. PMID: 41690405 [PubMed - as supplied by publisher]
	Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive bladder cancer; oncological and patient-reported outcomes of randomized controlled trial. Urol Oncol Elsawy AA, Laymon M, Ezzat O, Mansour I, Sobh AA, Nour EA, Mosbah A. PMID: 41689868 [PubMed - as supplied by publisher]
	MiRNA based liquid biopsy for castration-resistant prostate cancer diagnostics. Mol Cell Biochem Konoshenko MY, Saitkulova MM, Shutko EV, Ostaltsev IA, Laktionov PP, Bryzgunova OE. PMID: 41689709 [PubMed - as supplied by publisher]
	Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives. Discov Oncol Giunta EF, Schepisi G, Bleve S, Serra R, Brighi N, Torresan I, Tassinari E, Zanuccoli S, Lolli C. PMID: 41689691 [PubMed - as supplied by publisher]
	Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. Cancer Immunol Immunother Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L. PMID: 41689638 [PubMed - indexed for MEDLINE]
	Pharmacokinetics and Dosimetry of [(68)Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study. Cancer Biother Radiopharm Fan W, Li Y, Shi H, Guo J, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Ye D, Wang F, Wang J, Xu D, Jiang Z, Li H, Li J, Li R, Huo L, Ji Z. PMID: 41689461 [PubMed - as supplied by publisher]
	The Modified Frailty Index-5 as a Predictor of Postoperative Complications Following Radical Cystectomy. J Coll Physicians Surg Pak Dincer E, Ozkaptan O, Canakci C, Ipek OM, Coskun A, Can U. PMID: 41689329 [PubMed - indexed for MEDLINE]
	Magnetic resonance-guided simultaneous multi-foâ€‹cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study. Radiat Oncol Sun M, Qin SR, Wei R, Tian Y, Yan LL, Xia WL, Liu ZQ, Fu Q, Song YW, Fang H, Jing H, Wang SL, Li YX, Xing NZ, Lu NN. PMID: 41689033 [PubMed - as supplied by publisher]
	Is transurethral enucleation of the prostate combined with internal incision of peripheral zone abscesses a safe treatment for prostate multilocular abscesses? Aging Male Du J, Yuan X, Wang Y, Wang K, Wang L, Zhou H, Yu Z, Ren A, Lun X, Liu W, Shen T, Bi Y, Han B. PMID: 41688873 [PubMed - indexed for MEDLINE]
	Contemporary Role for Blue Light Cystoscopy Across the Bladder Cancer Disease Spectrum. Curr Urol Rep Wan E, Wade C, Sathe A, Ferguson JE 3rd, Peyton CC. PMID: 41688839 [PubMed - in process]
	The Relationship Between Prostate Cancer Treatments and Changes to Musculature: A Systematic Review. Clin Oncol (R Coll Radiol) Partridge L, Vickers A, McSweeney D, Shortall J, McWilliam A. PMID: 41688299 [PubMed - as supplied by publisher]
	Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study. Clin Genitourin Cancer Støyten M, Knutsen T, Thune I, Stikbakke E, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Schirmer H, Haugnes HS. PMID: 41688223 [PubMed - as supplied by publisher]
	Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care. Gene Bowling GC, Lacson JCA, Almeida AA, Rhee J, Chesnut GT, Nichols CR, Kern SQ. PMID: 41687980 [PubMed - as supplied by publisher]
	Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference Study. Urology Smith AB, Gore JL, Chisolm S, Squires P, Li H, Dave H, Mansfield C, Vass C. PMID: 41687978 [PubMed - as supplied by publisher]
	Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review. Int J Clin Oncol Abe J, Murashima T, Kojima S, Ueno T, Takei A, Nakai N, Akioka T, Kamoto T, Sawada A. PMID: 41686385 [PubMed - as supplied by publisher]
	Intensive nursing interventions for post-treatment anxiety and depression in bladder cancer: A systematic review and meta-analysis. Support Care Cancer Huang X, Chen R, Guo Z, Song C, Li X. PMID: 41686342 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 185482

Page 1 of 9275



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy